Why we founded BlueSkeye
Content Warning: Suicide
Why we founded BlueSkeye
Around 1 in 5 women experience a perinatal mental health problem during pregnancy or within the early postnatal years.
70% will hide or underplay their illness.
Suicide is the leading cause of direct maternal death within a year of having a baby.
BlueSkeye AI Helps Filmmaker Create Truly Interactive Movie
When University of Nottingham and Horizon Digital Economy Research academic and filmmaker Richard Ramchurn wanted to push the boundaries of how interactive a film could be, he turned to former colleague and entrepreneur Professor Michel Valstar.
Valstar’s start up, BlueSkeye AI, is a spin out from the University of Nottingham designed to commercialise the Professor’s 18 years of experience in affective computing and social signal processing. Experience which has led to the publication of over 100 papers, cited over 16000 times.
What is Affective Computing?
In today’s world, technology plays a crucial role in our daily lives. From smartphones to home appliances, technology has made our lives more convenient and efficient. However, technology has also made it possible to understand and interpret human emotions through the field of affective computing, sometimes known as emotion AI.
Will your next car know you have Alzheimer’s before your Doctor does?
Advances in machine learning, and over 18 years of academic research by myself and my team in affective computing and social signal processing have allowed us to develop software that can reliably and consistently identify signs of long term and acute illness.
Should they wish, car and truck manufacturers could easily, or with a little enhancement, incorporate the software into preexisting safety monitoring systems.
BlueSkeye AI appoint Naheed Visram as Vice President Sales and Marketing
Naheed Visram has joined BlueSkeye AI as Vice President Sales and Marketing.
How AI will revolutionise clinical trials
The increasing use of artificial intelligence looks set to revolutionise the pharmaceutical industry over the next few years.
There are implications for drug discovery, the development of highly targeted precision medicines and the potential to identify new treatment targets and repurpose existing drugs.
But one area that could be particularly significant is the introduction of affective computing and social signal processing to clinical trials with the potential to make such trials more efficient and effective.
Why the Mobile Phone is crucial to tackling the World’s growing mental health crisis.
The world is currently facing a mental health crisis post pandemic.
The World Health Organisation estimates that nearly a billion people worldwide are living with a mental disorder. In Europe around half of young people in the EU and a quarter of adults have unmet mental health needs whilst in the UK 8 million people in England with mental health problems cannot get specialist help because they are not considered sick enough to qualify.
These are sobering and miserable statistics. That is why in 2019 I and some of my colleagues at the University of Nottingham set up Blueskeye AI.
BlueSkeye AI awarded £20,000 for aerospace research project.
Blueskeye AI has been awarded £20,000 to investigate how face sensing technology can be used to obtain insights about human behaviour in the aircraft cockpit.
The research will identify the key drivers, enablers and barriers to using such technology in aircraft cockpits. It could pave the way for their adoption by the aerospace sector enhancing passenger and crew safety.
Healthtech start-up BlueSkeye AI raises £3.4m to transform mental health diagnoses
Award winning, early stage Healthtech company, BlueSkeye AI Ltd, has secured £3.4m in funding to pursue its mission to improve people’s quality of life through the use of its proprietary face and voice analysis technology. The round was led by XTX Ventures, which invested alongside Foresight Group (through The Midlands Engine Investment Fund), Praetura Ventures (through Praetura’s GMC Life Sciences Fund), the University of Nottingham and a consortium of high-net-worth individuals.
The joy of building things. My reflection on the internship at BlueSkeye AI
By Keerthy Kusumam
September 2020 – January 2021
I interned at BlueSkeye AI, a company that delivers ethical AI for supporting mental health for the vulnerable population using facial and voice behaviour analysis. The long term vision of BlueSkeye AI is to ’Create AI you can trust for a better future, together.’ The goals of my PhD aligns perfectly well with that of BlueSkeye, where comprehending various facial behaviours to recognise markers of mood disorders forms a core part of the work. The company BlueSkeye AI is cofounded by my PhD supervisor Prof Michel Valstar and the teammates include several of my past PhD colleagues. The following pointers are my reflections on my four-month-long internship at BlueSkeye AI.
Steve Cliffe joins BlueSkeye AI as it scales the development of its technology and customer portfolio.
BlueSkeye AI appoints Steve Cliffe to its board of directors.
BlueSkeye has deepened the deep tech expertise on its board by appointing former CEO of Ultraleap, Steve Cliffe as a Non-Executive Director and special advisor. Steve Cliffe joins BlueSkeye as the company scales and advances its ethical AI technology, partnerships and customer portfolio.
Maternal Mental Health Awareness Week
Maternal mental health awareness week is taking place this week, a campaign to raise awareness of mental health problems during and after pregnancy, to change attitudes surrounding maternal mental health and to advocate for mums to be able to access the information and support they need. During pregnancy and the postnatal period, many mothers experience heightened anxiety, feelings of isolation, judgement and guilt which are linked to pre-and postnatal depression and other mental health problems.